Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 4,539 |
| Other current assets | 0 | 0 | 0 | 0 | 191 |
| TOTAL | $0 | $N/A | $0 | $0 | $4,730 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 168 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $168 |
| Total Assets | $0 | $N/A | $0 | $0 | $5,216 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 173 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 1,349 |
| TOTAL | $0 | $N/A | $0 | $0 | $3,721 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 36 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $180 |
| Total Liabilities | $0 | $N/A | $0 | $0 | $3,900 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 1 |
| Retained earnings | 0 | N/A | 0 | 0 | -31,071 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10,000 |
| TOTAL | $0 | $N/A | $0 | $0 | $1,316 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $5,216 |